Alongside the great paradigm-shifting potential that arises from pharmaceutical innovation lurks a dangerous problem: a burgeoning … [Read more...]
Novel Targeting Techniques to Treat Breast, Ovarian and Other Drug Resistant Cancers Set to Start Phase I Clinical Trials in 2015
Over the past several years, researchers in the pharmaceutical industry have complained of a dearth of novel drug targets. … [Read more...]